切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2017, Vol. 11 ›› Issue (18) : 2223 -2228. doi: 10.3877/cma.j.issn.1674-0785.2017.18.003

所属专题: 文献

临床论著

TRPM4通道抑制剂9-菲酚在骨关节炎软骨细胞中的作用
刘笑君1, 杨朝晖1,(), 赵瑞鹏1   
  1. 1. 030001 太原,山西医科大学第二医院骨科
  • 收稿日期:2017-04-06 出版日期:2017-09-15
  • 通信作者: 杨朝晖

Role of TRPM4 channel inhibitor 9-phenanthrenol in osteoarthritis chondrocytes

Xiaojun Liu1, Zhaohui Yang1,(), Ruipen Zhao1   

  1. 1. Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2017-04-06 Published:2017-09-15
  • Corresponding author: Zhaohui Yang
  • About author:
    Corresponding author: Yang Zhaohui, Email:
引用本文:

刘笑君, 杨朝晖, 赵瑞鹏. TRPM4通道抑制剂9-菲酚在骨关节炎软骨细胞中的作用[J]. 中华临床医师杂志(电子版), 2017, 11(18): 2223-2228.

Xiaojun Liu, Zhaohui Yang, Ruipen Zhao. Role of TRPM4 channel inhibitor 9-phenanthrenol in osteoarthritis chondrocytes[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(18): 2223-2228.

目的

研究TRPM4信号通道抑制剂-9-菲酚对骨关节炎(OA)软骨细胞的肥大分化及软骨组织的降解的作用,并研究9-菲酚对OA软骨细胞凋亡的影响,从而为治疗OA提供实验依据。

方法

选取因OA进行膝关节置换而截下的胫骨平台关节软骨,消化成软骨细胞进行细胞培养。软骨细胞均分为6组,一组不加药作为对照组,其余分别加入不同量的。9-菲酚干预1 d培养后细胞分别进行RT-qPCR,检测Runx-2、MMP-13(软骨细胞肥大指标)及COL II、Aggrecan(软骨代谢指标);采用TUNEL染色荧光显微镜检测及Annexin V和7-AAD标记流式细胞仪检测9-菲酚干预1 d后OA软骨细胞凋亡情况。

结果

RT-qPCR显示:无法判断9-菲酚对软骨细胞代谢的影响;而软骨细胞肥大指标Runx-2、MMP13的mRNA较对照组表达水平有升高趋势,可见在mRNA水平上,9-菲酚可能促进软骨细胞肥大。TUNEL染色荧光显微镜检测软骨细胞凋亡率发现,9-菲酚浓度为2×10-5 mol/L组较对照组凋亡率明显下降(P<0.05),其他浓度组与对照组比较均无统计学差异,但均有凋亡率下降的趋势。Annexin V和7-AAD标记流式细胞仪检测软骨细胞凋亡率发现,9-菲酚浓度为1×10-5 mol/L、2×10-5 mol/L、4×10-5 mol/L时较对照组凋亡率均有所下降(P<0.05),而在另外两组有下降趋势。

结论

9-菲酚在细胞水平上对OA软骨细胞的肥大分化有促进作用,可能促进OA的进展。同时9-菲酚可以抑制OA软骨细胞的凋亡,在OA治疗方面可能具有积极意义。

Objective

To investigate whether TRPM4 channel inhibitor 9-phenanthrol can attenuate human osteoarthritis (OA) chondrocytes hypertrophy and cartilage explant matrix degeneration and to study the effect of 9-phenanthrol on apoptosis of OA chondrocytes to provide an experimental basis for the treatment of OA.

Methods

Human OA chondrocytes and cartilage explants, obtained from subjects with OA undergoing total knee arthroplasty, were cultured in the absence (blank group) or presence of different concentrations of 9-phenanthrol. Runx-2, MMP-13, COL II, and aggrecan mRNA expression was determined by real-time quantitative PCR (RT-qPCR) after 24 h of incubation. The effect of 9-phenanthrol on the apoptosis of OA chondrocytes was detected by TUNEL staining with fluorescence microscopy and flow cytometry with Annexin V and 7-AAD double staining after 1 day of incubation with 9-phenanthrol.

Results

According to RT-qPCR results, it was unable to judge the effect of 9-phenanthrol on hypertrophic differentiation and cell metabolism in OA chondrocytes, and the mRNA expression levels of chondrocyte hypertrophy indexes Runx-2 and MMP13 increased compared with the control group, suggesting that 9-phenanthrol may promote chondrocyte hypertrophy at the mRNA level. TUNEL staining with fluorescence microscopy showed that compared with the control group, the apoptosis rate of cells treated with 2×10-5 mol/L 9-phenanthrol was significantly decreased (P < 0.05), while no significant difference was observed in other concentration groups, although there was a decreasing trend compared with the control group. Flow cytometry with Annexin V and 7-AAD double staining showed that compared with the control group, the rate of apoptotic cartilage cells in the l×10-5 mol/L, 2×10-5 mol/L, and 4×10-5 mol/L 9-phenanthrol groups significantly decreased (P < 0.05), while no significant difference was observed in other two concentration groups, although there was a decreasing trend compared with the control group.

Conclusion

9-phenanthrenol promotes the proliferation and differentiation of OA chondrocytes at the cellular level and may promote the development of OA. However, 9-phenanthrenol can also reduce the apoptosis of OA chondrocytes and thus has positive significance in the treatment of OA.

表1 扩增引物序列表
图1 9-菲酚干预对OA软骨细胞基因表达的影响。图1a~图1d分别为蛋白多糖(AGG)、II型胶原(COL II)、Runx-2、MMP-13。RT-qPCR检测9-菲酚干预OA软骨细胞1天后,蛋白多糖(AGG)的mRNA在16U组表达减少,其他组有减少趋势,II型胶原(COL II)的mRNA表达除了1U组,其他组有增多趋势。Runx-2在4U、8U组表达增多,在其他组有增多趋势。MMP-13的mRNA在2U、4U、8U、16U组表达增多。与对照组比较,*P<0.05
图2 TUNEL染色荧光显微镜检测软骨细胞凋亡率结果,蓝色为DAPI染上的细胞核,红色为TUNEL染上的凋亡细胞
图3 9-菲酚干预对OA软骨细胞凋亡的影响,4U组较对照组凋亡率明显降低(P<0.05),其他组均有下降趋势
图4 Annexin V和7-AAD标记流式细胞仪检测软骨细胞凋亡率结果。经9-菲酚干预后,2U组、4U组和8U组与对照组相比,软骨细胞凋亡率明显下降(P<0.05),而4U组和8U组凋亡率有下降趋势,但没有统计学意义
[1]
李翱翔, 杨朝晖, 等. 瞬时受体通道M4与人膝关节软骨年龄变化及软骨破坏的关系. [J]. 中国临床实用医学, 2015(2): 21-24.
[2]
Guinamard R, Hof T, Del Negro CA. The TRPM4 channel inhibitor 9-phenanthro [J] . Br J Pharmacol, 2014, 171(7): 1600-1613.
[3]
Loeser RF. Osteoarthritis year in review 2013: biology [J]. Osteoarthritis Cartilage, 2013, 21(10): 1436-1442.
[4]
Li H, Li L, Min J, et al. Levels of metalloproteinase(MMP-3, MMP-9), NF-kappaB ligand(RANKL), and nitric oxide(NO) in peripheralblood of osteoarthritis(OA) patients [J]. Clin Lab, 2012, 58(7): 755-762.
[5]
Hunter DJ. Pharmacologic therapy for osteoarthritis-the era of diseasemodification [J]. Nat Rev Rheumatol, 2011, 7(1): 13-22.
[6]
Gerzanich V, Woo SK, Vennekens R, et al. De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury [J]. Nat Med, 2009, 15(2): 185-191.
[7]
Liu X, Schnellmann RG. Calpain mediates progressive plasma membrane permeability and proteolysis of cytoskeleton-associated paxillin, talin, and vinculin during renal cell death [J]. J Pharmacol Exp Ther, 2003, 304(1): 63-70.
[8]
Grand T, Demion M, Norez C, et al. 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels [J]. Br J Pharmacol, 2008, 153(8): 1697-1705.
[9]
卫小春. 关节软骨[M]. 北京: 科学技术出版社, 2007: 10-11.
[1] 闫文, 谢兴文, 顾玉彪, 雷宁波, 马成, 于文霞, 高亚雄, 张磊. 微小RNA与全膝关节置换术后深静脉血栓的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 842-846.
[2] 樊绪国, 赵永刚, 杨砚伟. 腓骨在膝骨关节炎作用的研究观点[J]. 中华关节外科杂志(电子版), 2023, 17(06): 855-859.
[3] 李善武, 叶永杰, 王兵, 王子呓, 银毅, 孙官军, 张大刚. 胫骨高位截骨与单髁置换的早期疗效比较[J]. 中华关节外科杂志(电子版), 2023, 17(06): 882-888.
[4] 张中斌, 付琨朋, 朱凯, 张玉, 李华. 胫骨高位截骨术与富血小板血浆治疗膝骨关节炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(05): 633-641.
[5] 陈宏兴, 张立军, 张勇, 李虎, 周驰, 凡一诺. 膝骨关节炎关节镜清理术后中药外用疗效的Meta分析[J]. 中华关节外科杂志(电子版), 2023, 17(05): 663-672.
[6] 王岩, 马剑雄, 郎爽, 董本超, 田爱现, 李岩, 孙磊, 靳洪震, 卢斌, 王颖, 柏豪豪, 马信龙. 外泌体在骨质疏松症诊疗中应用的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(05): 673-678.
[7] 赵之栋, 李众利. 骨关节炎早期诊治的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(05): 689-693.
[8] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[9] 王旭, 师绍敏, 毛燕, 季上, 刘亚玲. 肝酶代谢与骨关节炎相关性的研究进展[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 379-384.
[10] 周晓强, 孙超, 虞宵, 金宇杰, 李志强, 张向鑫, 陈广祥. 同一患者同期行全膝和单髁置换术的早期临床疗效[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 275-281.
[11] 马聪, 李雪靖, 郑晓佐, 张晓阳, 段坤峰, 刘国强, 郄素会. 关节腔内注射富血小板血浆与透明质酸钠治疗Ⅰ-Ⅲ期膝骨关节炎的对比研究[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 282-288.
[12] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[13] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[14] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要